HMPC starts Revision of GACP Guideline
Recommendation

19/20 May 2026
All relevant GMP/GACP aspects for Medical Cannabis
As previously announced, EMA´s HMPC is currently working on the revision of the Guideline on Good Agricultural and Collection Practice (GACP).
The goal is to draft a concept paper for revision to address stakeholder requests on required clarifications, e.g.
- overlap GMP vs. GACP,
- uncertainty about requirements,
- GACP certification and dossier,
- comparison to other GACP standards such as WHO.
The committee now adopted a concept paper for the revision of the Guideline on Good Agricultural and Collection Practice (GACP) of starting materials of herbal origin. The concept paper on the revision of guideline EMA/HMPC/246816/2005 will be published at EMA´s Herbal medicinal products: scientific guidelines website. Interested parties are invited to provide comments by 15 March 2022.
Please find more information in the HMPC meeting report of the 102nd HMPC meeting.
Related GMP News
23.04.2026EMA publishes Draft Guideline on the Declaration of Active Substances in Herbal Drugs
23.04.2026Plans to reclassify Hexahydrocannabinol
02.04.2026What are the GMP Requirements for Medical Cannabis?
02.04.2026EFSA sets Cannabidiol (CBD) Safety Limit
02.04.2026What are the GMP Requirements for Herbal Medicinal Products?
03.03.2026Can Steam Treatment be used to Decontaminate Cannabis?


